Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues

This publication has 9 references indexed in Scilit:

• Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy
  AIDS, 2003
• Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons
  JAMA, 2002
• Antiretroviral Treatment for Adult HIV Infection in 2002
  JAMA, 2002
• Prevalence and Conditions of Selection of E44D/A and V118I Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in Clinical Practice
  Antimicrobial Agents and Chemotherapy, 2001
• Implications of antiretroviral resistance on viral fitness
  Current Opinion in Infectious Diseases, 2001
• Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
  AIDS, 2001
• Prevalence of Novel Lamivudine-Resistant Genotypes (E44D/A, V118I) in Naive and Pretreated HIV-Infected Individuals
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V
  Antimicrobial Agents and Chemotherapy, 2000
• Antiviral Activities of 9- R -2-Phosphonomethoxypropyl Adenine (PMPA) and Bis(isopropyloxymethylcarbonyl)PMPA against Various Drug-Resistant Human Immunodeficiency Virus Strains
  Antimicrobial Agents and Chemotherapy, 1998